Week in review: Atropine microdose, errant injection, ocular COVID
- Posted on: Oct 16 2020
- Leave a response
This week, Bausch acquires a microdose formulation of atropine, an injection of hyaluronic acid leads to severe complications and researchers report SARS-CoV-2 antigens can linger in ocular tissues months after the infection has passed.
Source: AAO
Posted in: Uncategorized